ADAR and neoplasm: High‐throughput sequencing studies indicate that the expression of ADAR1 is elevated in BRCA [18, 19, 20], and gene mutations caused by its mediated RNA editing lead to reduced production of interferons and other inflammatory mediators and promote tumour immune escape [21].